Episurf Medical (EPIS-B.ST) Stock Analysis & AI Equity Report
Episurf Medical (EPIS-B.ST) overview
Episurf Medical (EPIS-B.ST) stock analysis and AI equity research. For the latest completed financial year, 2025, Episurf Medical reported revenue of SEK 13.5m and operating profit of SEK -60.4m; the year-end share price was 0.04 SEK and market capitalisation was SEK 36.6m. Episurf Medical is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Episurf Medical's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.
Key metrics & valuation multiples
Figures updated on 2026-05-21. Data will be refreshed during report generation.
About Episurf Medical
Episurf Medical develops and markets patient-specific orthopedic implants and associated surgical instruments for focal cartilage and osteochondral lesions, mainly in the knee, ankle and patellofemoral joint. Its Episealer products use MRI- or CT-based 3D modeling and custom manufacturing to support surgeons with personalized joint-preservation treatment.
Generate the Episurf Medical report
Episurf Medical is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.
Sources & methodology
Financial figures are sourced from Valuatum's financial model for Episurf Medical and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.
Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.